Results 41 to 50 of about 387,621 (269)
“Wit” Teaching About Death, Dying, Clinical Trials, and DNR
MedEdPORTAL, 2009 Introduction This resource is a small-group activity aimed to facilitate discussions after a viewing of the Emmy award-winning movie “Wit.” The facilitator's guide and accompanying materials will enable faculty to lead small groups to effectively discuss
Jeffrey Spike, Christie Sain
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2022 Vaccination toward SARS-CoV-2 reduced mortality and ‘boosters’ are being implemented. We offer scientific contribution about IgG production in the COVID-19 experienced population.
Fabio Borgonovo +14 more
doaj +1 more source
Pharmaceutics, 2023 Neutralizing antibodies (nAbs), the popular antiviral drugs used for the treatment of COVID-19, are effective in reducing viral load and hospitalization.
Zhiyin An +8 more
doaj +1 more source
Drugs and Drug Candidates, 2023 Bioactive compounds against SARS-CoV-2 targets could be potential treatments for COVID-19. Inhibitors of the receptor-binding domain (RBD) on the viral spike protein can block its binding to the human angiotensin-converting enzyme type II (ACE2) receptor.
Camila Fonseca Amorim da Silva +6 more
doaj +1 more source
Spike Train Decoding Without Spike Sorting [PDF]
Neural Computation, 2008 We propose a novel paradigm for spike train decoding, which avoids entirely spike sorting based on waveform measurements. This paradigm directly uses the spike train collected at recording electrodes from thresholding the bandpassed voltage signal.
openaire +3 more sources
Current and Future Direct-Acting Antivirals Against COVID-19
Frontiers in Microbiology, 2020 The coronavirus disease of 2019 (COVID-19) has caused an unprecedented global crisis. The etiological agent is a new virus called the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). As of October, 2020 there have been 45.4 million confirmed
Shiu-Wan Chan
doaj +1 more source
mBio, 2021 The spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been identified as the prime target for vaccine development. The spike protein mediates both binding to host cells and membrane fusion and is also so far the only known
Fatima Amanat +6 more
doaj +1 more source
Rethinking, Returning, Reflecting [PDF]
Alternatif Politika, 2017 After almost four decades of feminist International Relations (IR), I here rethink the journey this has entailed – for myself and others -- and contemplate where it has taken us.
V. Spike Peterson
doaj
Comparative Analysis and Classification of SARS-CoV-2 Spike Protein Structures in PDB
COVID, 2023 The Spike (S) protein of the SARS-CoV-2 virus that causes the COVID-19 disease is considered the most important target for vaccine, drug and therapeutic research as it attaches and binds to the ACE2 receptor of the host cells and allows the entry of this
Memoona Aslam +3 more
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Children with acute lymphoblastic leukemia (ALL) are at risk of severe outcomes from SARS‐CoV‐2 (SCV2). In the post‐pandemic context, where most children have been infected with SCV2, there are limited data on whether vaccination remains beneficial in children with ALL.
Janna R. Shapiro +11 more
wiley +1 more source